{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneShortName": "EDT", "exchangeTimezoneName": "America/New_York", "esgPopulated": false, "regularMarketChangePercent": -26.666666, "currency": "USD", "regularMarketPrice": 0.011, "messageBoardId": "finmb_266261407", "gmtOffSetMilliseconds": -14400000, "marketState": "REGULAR", "market": "us_market", "exchange": "PNK", "shortName": "TETRA BIO PHARMA INC", "longName": "Tetra Bio-Pharma Inc.", "firstTradeDateMilliseconds": 1348579800000, "priceHint": 4, "regularMarketChange": -0.0039999997, "regularMarketTime": 1684246441, "regularMarketDayHigh": 0.011, "regularMarketDayRange": "0.01 - 0.011", "regularMarketDayLow": 0.01, "regularMarketVolume": 14354, "regularMarketPreviousClose": 0.015, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Other OTC", "financialCurrency": "CAD", "regularMarketOpen": 0.01, "averageDailyVolume3Month": 77966, "averageDailyVolume10Day": 70300, "fiftyTwoWeekLowChange": 0.0010000002, "fiftyTwoWeekLowChangePercent": 0.10000002, "fiftyTwoWeekRange": "0.01 - 0.1", "fiftyTwoWeekHighChange": -0.089, "fiftyTwoWeekHighChangePercent": -0.89, "fiftyTwoWeekLow": 0.01, "fiftyTwoWeekHigh": 0.1, "earningsTimestamp": 1666004340, "earningsTimestampStart": 1684234740, "earningsTimestampEnd": 1684497600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.06, "sharesOutstanding": 423363008, "bookValue": -0.014, "fiftyDayAverage": 0.020508, "fiftyDayAverageChange": -0.009508001, "fiftyDayAverageChangePercent": -0.46362397, "twoHundredDayAverage": 0.025905, "twoHundredDayAverageChange": -0.014905, "twoHundredDayAverageChangePercent": -0.57537156, "marketCap": 6215428, "priceToBook": -0.78571427, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "displayName": "Tetra Bio-Pharma", "symbol": "TBPMF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2316 St. Joseph Boulevard", "city": "Orl\u00e9ans", "state": "ON", "zip": "K1C 1E8", "country": "Canada", "website": "https://www.tetrabiopharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orl\u00e9ans, Canada.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Dr. Guy  Chamberland M.Sc., Master Herbal", "age": 60, "title": "Co-Founder, CEO, Chief Regulatory Officer & Director", "yearBorn": 1962, "fiscalYear": 2021, "totalPay": {"raw": 237833, "fmt": "237.83k", "longFmt": "237,833"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Steeve  N\u00e9ron", "title": "Chief Commercial Officer", "fiscalYear": 2021, "totalPay": {"raw": 204233, "fmt": "204.23k", "longFmt": "204,233"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andr\u00e9  Rancourt B.Sc.", "title": "Co-Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Leslie  Auld CPA, M.B.A.", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Jennifer  McCaughey", "title": "VP of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Dania  Scott B.Sc.", "title": "Sr. VP of Commercial Strategy", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Aurelia De Pauw", "title": "Sr. VP of Clinical Programs & Medical Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Richard  Giguere", "title": "Chief Exec. Officer of Tetra Natural Health Inc.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Randy  Ringuette", "title": "Project Director & Member of Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Chris  MacLean", "title": "Chief Operating Officer of Tetra Natural Health", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}